2min chapter

Growth & Failure cover image

Dr. Aoife Brennan, President & CEO of Synlogic Therapeutics

Growth & Failure

CHAPTER

Rare Disease Innovation Unit at Biogin

The former head of rare disease innovation at biogin is now president in co of sin logic. What encouraged him to leave the company and join sonagi? And if you could describe what sinlogic is happy to so bi thall end the time, i probably would have stayed at bigen If they had continued to pursuit te rare disease focus strategy.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode